![Andrew Bolt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Bolt
Vorstandsvorsitzender bei SphynKx Therapeutics LLC
Profil
Andrew Bolt is the founder of SphynKx Therapeutics LLC, which he founded in 2010 and where he currently holds the titles of President & Chief Executive Officer.
Mr. Bolt's former jobs include being a Principal at Millennium Pharmaceuticals, Inc. and Deloitte Consulting LLP, as well as a Cancer Biologist at Millennium Predictive Medicine, Inc. Mr. Bolt's education includes an undergraduate and graduate degree from the University of Connecticut and an MBA from the University of Virginia Darden School of Business.
Aktive Positionen von Andrew Bolt
Unternehmen | Position | Beginn |
---|---|---|
SphynKx Therapeutics LLC
![]() SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology SphynKx Therapeutics LLC engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis. Its Sphingosine 1-phosphate (S1P) is recognized as a key regulator of many of the cellular processes that promote wound healing and fibrogenesis, which include fibroblast and immune cell migration, vascular leak, proliferation, angiogenesis, and TGF-ß signaling. The company was founded by Andrew Bolt, Kevin R. Lynch, Webster Santos and Timothy L. Macdonald in 2010 and is headquartered in Charlottesville, VA. | Vorstandsvorsitzender | 01.01.2010 |
Ehemalige bekannte Positionen von Andrew Bolt
Unternehmen | Position | Ende |
---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Deloitte Consulting LLP
![]() Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Millennium Predictive Medicine, Inc. | Corporate Officer/Principal | - |
Ausbildung von Andrew Bolt
University of Connecticut | Graduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte Consulting LLP
![]() Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Commercial Services |
Millennium Predictive Medicine, Inc. | |
SphynKx Therapeutics LLC
![]() SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology SphynKx Therapeutics LLC engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis. Its Sphingosine 1-phosphate (S1P) is recognized as a key regulator of many of the cellular processes that promote wound healing and fibrogenesis, which include fibroblast and immune cell migration, vascular leak, proliferation, angiogenesis, and TGF-ß signaling. The company was founded by Andrew Bolt, Kevin R. Lynch, Webster Santos and Timothy L. Macdonald in 2010 and is headquartered in Charlottesville, VA. | Health Technology |